Nektar Therapeutics (NKTR)
1.235
-0.08
(-6.44%)
USD |
NASDAQ |
Apr 19, 15:36
Nektar Therapeutics Price: 1.235 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 1.32 | 1.36 | 1.27 | 1.32 | 3.538M |
| Apr 17, 2024 | 1.48 | 1.50 | 1.28 | 1.35 | 3.262M |
| Apr 16, 2024 | 1.47 | 1.575 | 1.45 | 1.49 | 1.593M |
| Apr 15, 2024 | 1.68 | 1.70 | 1.50 | 1.57 | 2.847M |
| Apr 12, 2024 | 1.58 | 1.675 | 1.48 | 1.67 | 4.832M |
| Apr 11, 2024 | 1.40 | 1.75 | 1.36 | 1.58 | 13.19M |
| Apr 10, 2024 | 1.21 | 1.39 | 1.16 | 1.29 | 4.904M |
| Apr 09, 2024 | 1.30 | 1.34 | 1.24 | 1.25 | 2.079M |
| Apr 08, 2024 | 1.34 | 1.395 | 1.22 | 1.31 | 3.137M |
| Apr 05, 2024 | 1.32 | 1.47 | 1.26 | 1.32 | 5.026M |
| Apr 04, 2024 | 1.08 | 1.39 | 1.08 | 1.32 | 11.16M |
| Apr 03, 2024 | 0.9796 | 1.13 | 0.95 | 1.04 | 3.581M |
| Apr 02, 2024 | 0.903 | 1.02 | 0.8998 | 0.95 | 3.597M |
| Apr 01, 2024 | 0.93 | 0.949 | 0.902 | 0.9041 | 1.192M |
| Mar 28, 2024 | 0.88 | 0.94 | 0.8626 | 0.9342 | 1.316M |
| Mar 27, 2024 | 0.88 | 0.9272 | 0.84 | 0.8851 | 1.242M |
| Mar 26, 2024 | 0.90 | 0.9297 | 0.8902 | 0.90 | 1.468M |
| Mar 25, 2024 | 0.92 | 0.9276 | 0.8881 | 0.8881 | 1.708M |
| Mar 22, 2024 | 0.90 | 0.9199 | 0.8950 | 0.9135 | 778497.0 |
| Mar 21, 2024 | 0.913 | 0.927 | 0.8904 | 0.8973 | 771746.0 |
| Mar 20, 2024 | 0.87 | 0.91 | 0.8682 | 0.90 | 682918.0 |
| Mar 19, 2024 | 0.832 | 0.9086 | 0.832 | 0.8682 | 959947.0 |
| Mar 18, 2024 | 0.831 | 0.8598 | 0.831 | 0.85 | 494324.0 |
| Mar 15, 2024 | 0.8433 | 0.8683 | 0.83 | 0.8602 | 870442.0 |
| Mar 14, 2024 | 0.87 | 0.89 | 0.83 | 0.86 | 1.175M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4227
Minimum
Nov 28 2023
36.27
Maximum
Jul 03 2019
12.29
Average
15.37
Median
Dec 21 2021
Price Benchmarks
| Stereotaxis Inc | 2.49 |
| Vanda Pharmaceuticals Inc | 5.18 |
| Cara Therapeutics Inc | 0.682 |
| Marinus Pharmaceuticals Inc | 1.39 |
| DiaMedica Therapeutics Inc | 2.42 |
Price Related Metrics
| PS Ratio | 2.604 |
| Price to Book Value | 1.731 |
| Earnings Yield | -118.2% |
| Market Cap | 226.77M |